Several studies investigated its low expression profiles in glioblastoma [21] and declared ABLIM1 might act as a tumor suppressor in glioblastoma [21], nasopharyngeal carcinoma [30], and melanoma [22], however the underlying mechanism remains unclear. Here, ABLIM1 is linked to nasopharyngeal carcinoma.